Lymphocyte activation gene-3 (LAG-3) and cluster of differentiation-155 (CD-155) expression by immunohistochemistry do not predict response and survival in non-small lung cancer (NSCLC) patients treated with second-line nivolumab treatment
Rollas A. E. A., Erman M., Onder S. C.
JOURNAL OF THORACIC ONCOLOGY, no.3, 2025 (SCI-Expanded, Scopus)
-
Publication Type:
Article / Abstract
-
Publication Date:
2025
-
Journal Name:
JOURNAL OF THORACIC ONCOLOGY
-
Journal Indexes:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, MEDLINE
-
Hacettepe University Affiliated:
Yes